The new UK innovation tsar will need to drill deep to tackle the country’s patent lag

British businesses have demonstrated their innovative capacity time and again, but their consistent failure to develop the IP that secures it is a problem that must be addressed

19 June 2021

Increasing diversity in innovation – a call to action

If the US is to compete successfully with China and the rest of the world it must make use of all the talent at its disposal – and that means ensuring more women get to the cutting edge of the invention process

12 June 2021

Increasing R&D and infrastructure investment is vital to US tech success

If the 21st century is to be another American one, both the government and business must commit to higher spending to strengthen the foundations on which innovation is built

05 June 2021

China's courts deserve a bigger say in global SEP policy

The country’s judges are ready and willing to play a greater role in shaping the world’s licensing landscape, but they must do more to win confidence abroad

29 May 2021

Six questions for an IP market at a critical turning point

Jacob Schindler identifies some of the key issues he will be focusing on as he assumes the IAM editor’s chair

22 May 2021

The final filing ...

After seven years and many memorable moments with IAM, Richard Lloyd signs-off as editor

15 May 2021

Biden’s backing for the covid vaccine IP waiver should concern all rights owners

This week’s unprecedented move raises a series of worrying questions and puts in doubt the administration’s commitment to fostering innovative activity

08 May 2021

Patent counting is here to stay – and the 6G horse race has already begun

Like it or not, governments think quantity matters and SEP portfolios are fast becoming a key metric for great power competition in the information age

01 May 2021

Why high-tech patent expertise will be increasingly valued by life sciences companies

If the experience of NantWorks’ IP chief Mark Kokes is anything to go by, leading strategists from other sectors can make a splash in pharma and biotech

24 April 2021

A $2 billion exclusion order and the future of the ITC

The outcome of the recent high-profile dispute between LG Energy Solutions and SK Innovation shows that the commission offers IP owners the prospect of significant leverage against alleged transgressors of their rights - and that means it will remain a target for reform

17 April 2021

The Tillis USPTO Director red lines have real political bite

The North Carolina senator is clear that the he will not vote to confirm a nominee who will row back on the Iancu reforms

10 April 2021

Beware the flow of money into China’s transactions space

Saturday Opinion: Encouraging patent deals and lending through metrics and incentives could lay a trap for those who want a higher-quality patent system

03 April 2021

Patent owners need to get wise to a possible changing of the guard at the Federal Circuit

Judge Wallach’s decision to take senior status might be the first of several and with billions in recent damages verdicts heading the court’s way, any new appointments could prove particularly consequential

27 March 2021

China’s IP world is set for a big shift to auto

Huawei, ZTE and other leading domestic high-tech players are moving in and they will help shape the landscape for transactions, litigation and licensing

20 March 2021

Patent licensing does not deserve the unfair rap it gets

Everyone in the IP eco-system should promote the benefits of an activity that has delivered so much to so many in all parts of the world – but recognise its flaws, too

13 March 2021

Creative monetisation of de-prioritised IP is the next frontier for Big Pharma strategists

Despite their commitments to specialisation, large life sciences companies must not neglect the value of sidelined patents, know-how and other intangible assets

06 March 2021

India is staring at some of the biggest opportunities in global IP

Decision to abolish troubled patent board is the right one, but policymakers should double down on reform

27 February 2021

Why the US must now take the lead on SEP FRAND

Being a rule taker does not sit well with American interests nor with those of the wider global patent community. It is time for a change of approach

20 February 2021

The cleantech gap in Big Oil patent portfolios spells more M&A in the sector

The supermajors are not creating big IP stockpiles in green energy, which means there could be opportunities for others

13 February 2021

No, IP rights are not the barrier to covid-19 vaccine supplies

Continued criticism of biopharma patent owners fails to acknowledge that manufacturing and supply complexities are the real obstacles to mass inoculation around the world

06 February 2021

Unlock unlimited access to all IAM content